IL76591A0 - Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof - Google Patents

Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof

Info

Publication number
IL76591A0
IL76591A0 IL76591A IL7659184A IL76591A0 IL 76591 A0 IL76591 A0 IL 76591A0 IL 76591 A IL76591 A IL 76591A IL 7659184 A IL7659184 A IL 7659184A IL 76591 A0 IL76591 A0 IL 76591A0
Authority
IL
Israel
Prior art keywords
ypsilon
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL76591A
Other languages
English (en)
Original Assignee
Bioferon Biochem Substanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27192400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL76591(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE3436638A external-priority patent/DE3436638C2/de
Priority claimed from DE19843436637 external-priority patent/DE3436637A1/de
Application filed by Bioferon Biochem Substanz filed Critical Bioferon Biochem Substanz
Priority claimed from DE19853521733 external-priority patent/DE3521733A1/de
Publication of IL76591A0 publication Critical patent/IL76591A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL76591A 1984-10-05 1984-10-06 Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof IL76591A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3436638A DE3436638C2 (de) 1984-10-05 1984-10-05 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
DE19843436637 DE3436637A1 (de) 1984-10-05 1984-10-05 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
DE19853521733 DE3521733A1 (de) 1985-06-18 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung

Publications (1)

Publication Number Publication Date
IL76591A0 true IL76591A0 (en) 1986-02-28

Family

ID=27192400

Family Applications (2)

Application Number Title Priority Date Filing Date
IL76591A IL76591A0 (en) 1984-10-05 1984-10-06 Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
IL76591A IL76591A (en) 1984-10-05 1985-10-06 Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL76591A IL76591A (en) 1984-10-05 1985-10-06 Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases

Country Status (6)

Country Link
US (1) US5145677A (fr)
EP (2) EP0181455B2 (fr)
CA (1) CA1288694C (fr)
DE (1) DE3583849D1 (fr)
DK (1) DK174585B1 (fr)
IL (2) IL76591A0 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149551A3 (fr) * 1984-01-16 1987-09-23 Genentech, Inc. Compositions synergétiques d'interféron gamma-interleukine 2 et procédés de préparation
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
WO1987005518A1 (fr) * 1986-03-17 1987-09-24 Schering Corporation Traitement de cancers a l'aide de l'interferon gamma
ATE67675T1 (de) * 1986-06-17 1991-10-15 Biogen Inc Kombination von gammainterferonen und antientzuendungsmitteln oder antipyretischen mitteln zur behandlung von krankheiten.
CA1340698C (fr) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation et utilisations de l'interferon gamma
CA1320905C (fr) 1986-11-06 1993-08-03 Joseph M. Cummins Traitement d'affections immuno-resistantes
EP0278715A3 (fr) * 1987-02-09 1989-03-08 Schering Corporation Utilisation d'interféron gamma humain pour le traitement du carcinome de cellules basales
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
WO1989008461A1 (fr) * 1988-03-07 1989-09-21 Centocor, Inc. Composition d'interferons gamma destinee a supprimer l'action du systeme immunitaire
FR2644067B1 (fr) * 1989-02-02 1993-02-05 Roussel Uclaf Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale
ATE121945T1 (de) * 1989-12-01 1995-05-15 Childrens Medical Center Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma.
JP2587711B2 (ja) * 1990-05-09 1997-03-05 大塚製薬 株式会社 抗腫瘍剤
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
TW218846B (fr) * 1992-04-07 1994-01-11 Ciba Geigy
EP0704220A1 (fr) * 1994-09-30 1996-04-03 Dr. Rentschler Biotechnologie GmbH Utilisation de médicaments contenant le bêta interféron
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
CA2329474C (fr) 1995-11-02 2002-02-26 Schering Corporation Therapie par perfusion continue a faible dosage de cytokine
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
NZ332689A (en) 1996-05-09 2000-07-28 Pharma Pacific Pty Ltd Using interferon to treat autoimmune, mycobacterial or neurodegenerative disease
US20030108519A1 (en) * 1996-05-09 2003-06-12 Pharma Pacific Pty Ltd. Therapeutic applications of high dose in terferon
CN1320044A (zh) 1998-08-11 2001-10-31 Idec药物公司 包括施用抗－cd20抗体的b－细胞淋巴瘤联合疗法
KR20010099788A (ko) * 1998-11-09 2001-11-09 케네쓰 제이. 울코트 Ｂｍｔ 또는 ｐｂｓｃ 이식을 받은 환자의 키메라항-ｃｄ２０ 항체 치료법
RU2140286C1 (ru) * 1999-04-28 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - глазные капли "офтальмоферон"
US20040228871A1 (en) * 1999-06-03 2004-11-18 Tayyaba Hasan Treatment and analysis of proliferative disorders
EP1066834A3 (fr) * 1999-07-08 2004-06-02 Thomas Dr. Stief Compositions pharmaceutiques comprenant un agent modulateur des phagocytes
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
EP1227831A2 (fr) * 1999-11-10 2002-08-07 Mondobiotech SA Interferon gamma pour le traitement de l'asthme
WO2001041782A2 (fr) * 1999-12-09 2001-06-14 Chiron Corporation Procede d'administration de cytokine aux systeme nerveux central et systeme lymphatique
WO2001074384A1 (fr) * 2000-03-31 2001-10-11 Aronex Pharmaceuticals, Inc. Interferon alfa et acide all-trans retinoique liposomal encapsule combines, preparation et utilisation
WO2002087606A2 (fr) * 2000-12-20 2002-11-07 Sri International Modulateurs du systeme de l'hypocretine et methodes de criblage associees
AU2002315168A1 (en) * 2001-06-14 2003-01-02 Intermune, Inc. Combination therapy of gamma-interferon and b cell specific antibodies
JP2004535464A (ja) * 2001-07-20 2004-11-25 インターミューン インコーポレイテッド 肝臓の線維症を治療する方法
US6911198B2 (en) * 2001-09-17 2005-06-28 Yeda Research And Development Co. Ltd. Method and pharmaceutical composition for treating inflammation
PL371683A1 (en) * 2001-10-05 2005-06-27 Intermune, Inc. Methods of treating liver fibrosis and hepatitis c virus infection
ATE544453T1 (de) * 2002-07-15 2012-02-15 Gilead Sciences Inc Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen
US20060110358A1 (en) * 2002-08-28 2006-05-25 Hsu Henry H Combination therapy for treatment of fibrotic disorders
EP1430902A1 (fr) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Composition pharmaceutique comprenant l'interferon gamma avec diagnostic moléculaire pour un meilleur traitment de l'asthme
EP1582216A4 (fr) * 2002-12-26 2010-04-21 Asubio Pharma Co Ltd Medicament permettant de traiter la pemphigoide
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
CN113993522A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗焦虑障碍、头痛病症和进食障碍的方法
JP2023516774A (ja) * 2020-03-06 2023-04-20 サントル、オスピタリエ、ユニヴェルシテール、ド、ニーム 筋萎縮性側索硬化症の治療のための低用量ヒトインターロイキン－２
WO2023072853A1 (fr) * 2021-10-25 2023-05-04 Ellennbe Gmbh Forme posologique injectable et kit comprenant une substance immunomodulatrice pour le traitement de maladies

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4460685A (en) 1980-05-29 1984-07-17 New York University Method of enhancing the production of human γ Interferon
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
US4376821A (en) 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
EP0090837A1 (fr) * 1981-10-08 1983-10-12 BERG, Kurt Frimann Procede et composition de traitement d'un patient presentant des troubles sensible a l'interferon
DE3278234D1 (en) 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
EP0080032A3 (fr) 1981-11-20 1985-11-13 Enzo Biochem, Inc. Préparation pharmaceutique pour le traitement de lésions herpétiques
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
DE3381553D1 (de) * 1982-10-25 1990-06-21 Genentech Inc Synergistische humaninterferonaktivitaet.
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4461757A (en) 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
IL71954A0 (en) * 1983-06-01 1984-09-30 Genentech Inc Gamma interferon-lymphotoxin synergism
CA1265444A (fr) * 1983-06-27 1990-02-06 Lloyd J. Old Effet du facteur humain de necrose des tumeurs et de l'interferon humain sur des cellules cancereuses humaines et methodes utilisees
EP0149551A3 (fr) * 1984-01-16 1987-09-23 Genentech, Inc. Compositions synergétiques d'interféron gamma-interleukine 2 et procédés de préparation
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
FR2611031B1 (fr) * 1987-02-16 1989-05-05 Commissariat Energie Atomique Refrigerateur, notamment a cycle de vuilleumier, comportant des pistons suspendus par des paliers a gaz

Also Published As

Publication number Publication date
EP0177910A3 (fr) 1986-07-02
AU588547B2 (en) 1989-09-21
DK452485D0 (da) 1985-10-04
EP0181455B1 (fr) 1991-08-21
DK174585B1 (da) 2003-07-07
DK452485A (da) 1986-04-06
IL76591A (en) 1991-06-10
EP0181455B2 (fr) 2000-05-31
EP0181455A2 (fr) 1986-05-21
US5145677A (en) 1992-09-08
EP0177910A2 (fr) 1986-04-16
CA1288694C (fr) 1991-09-10
AU4841285A (en) 1986-04-10
DE3583849D1 (de) 1991-09-26
EP0181455A3 (en) 1986-06-04

Similar Documents

Publication Publication Date Title
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
IL75400A0 (en) Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA859756B (en) Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same
IL75120A0 (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
GB2153678B (en) Pharmaceutical composition
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
EP0163178A3 (en) Pharmaceutical composition
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
EG17710A (en) Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them
GB2153677B (en) Pharmaceutical composition
ZA862141B (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
IL78576A0 (en) 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
IL74667A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
GB8410636D0 (en) Pharmaceutical substances/compositions
GB2184726B (en) Azoniaspironortropanol esters, processes for the preparation thereof and pharmaceutical compositions containing them
PT79990A (en) Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith
ZA853375B (en) New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them
GB2153676B (en) Pharmaceutical composition
IL78230A0 (en) Substituted 1,8-naphthyridinones,processes for their preparation and pharmaceutical compositions containing them
GB8429710D0 (en) Pharmaceutical composition
IL82588A (en) Androstan-17-one and androsten-17-one derivatives and pharmaceutical compositions containing the same